![Jacobin | NicePNG](https://ifp.nyu.edu/wp-content/uploads/2024/04/1-180.jpg)
Jacobin | NicePNG
Teaming up with Big Pharma and Wall Street, universities are profiting by fighting government efforts to curtail soaring drug prices. A case in point: UCLA has reaped more than a billion dollars from its development of Xtandi, a lifesaving cancer drug.